1-3 of 3
M. Anna Zal
Close
Sort by
Journal Articles

Combined Blockage of E-Selectin and CXCR4 (GMI-1359) Enhances Anti-Leukemia Effect of FLT3 Inhibition (Sorafenib) and Protects Hematopoiesis in Pre-Clinical AML Models

Weiguo Zhang, MD PhD, Kyung Hee Chang, PhD, Mahesh Basyal, BS, Yannan Jia, Lauren B Ostermann, BS, William E. Fogler, PhD, John L. Magnani, PhD, M Anna Zal, BS., MS, Tomasz Zal, PhDMSc, Michael Andreeff, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-140984
Published: 2020
Journal Articles

Anti-Leukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody-Conjugate in Acute Myeloid Leukemia

Lina Han, PhD, Eric Rowinsky, MD, Christopher Brooks, PhD, Tomasz Zal, M. Anna Zal, Jared K Burks, PhD, Jin Zhou, MD PhD, Stefan O. Ciurea, MD, Gheath Alatrash, Jorge E. Cortes, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD, Farhad Ravandi, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 981.
https://doi.org/10.1182/blood.V124.21.981.981
Published: 2014
Journal Articles

The Dynamics of Stroma-Leukemia Interaction in the Hypoxic BM Niches in Vivo

Karine G. Harutyunyan, PhD, Felix Nwajei, M. Anna Zal, David A Fruman, PhD, Saradhi Mallampati, PhD, Xiaoping Sun, MD PhD, Tomasz Zal, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2396.
https://doi.org/10.1182/blood.V124.21.2396.2396
Published: 2014